These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22566103)

  • 21. Macrovascular and microvascular outcomes after beginning of insulin versus additional oral glucose-lowering therapy in people with type 2 diabetes: an observational study.
    Hall GC; McMahon AD; Carroll D; Home PD
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):305-13. PubMed ID: 22271442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients.
    Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Nunez L; Gudbjörnsdóttir S; Eliasson B
    Diabetologia; 2009 Jan; 52(1):65-73. PubMed ID: 18985314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study.
    Jørgensen CH; Gislason GH; Andersson C; Ahlehoff O; Charlot M; Schramm TK; Vaag A; Abildstrøm SZ; Torp-Pedersen C; Hansen PR
    Cardiovasc Diabetol; 2010 Sep; 9():54. PubMed ID: 20843380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 2 diabetes mellitus increases the mortality risk after acute coronary syndrome treated with coronary artery bypass surgery.
    Ram E; Sternik L; Klempfner R; Iakobishvili Z; Fisman EZ; Tenenbaum A; Zuroff E; Peled Y; Raanani E
    Cardiovasc Diabetol; 2020 Jun; 19(1):86. PubMed ID: 32534591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients with insulin-treated versus non-insulin-treated diabetes mellitus.
    Hoebers LP; Claessen BE; Woudstra P; DeVries JH; Wykrzykowska JJ; Vis MM; Baan J; Koch KT; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    EuroIntervention; 2014 May; 10(1):90-6. PubMed ID: 24832639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients with Type 2 Diabetes Mellitus.
    Yen FS; Wang HC; Pan CW; Wei JC; Hsu CC; Hwu CM
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31544207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart.
    Anselmino M; Ohrvik J; Malmberg K; Standl E; Rydén L;
    Eur Heart J; 2008 Jan; 29(2):177-84. PubMed ID: 18156611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin use and increased risk of mortality in type 2 diabetes: a cohort study.
    Gamble JM; Simpson SH; Eurich DT; Majumdar SR; Johnson JA
    Diabetes Obes Metab; 2010 Jan; 12(1):47-53. PubMed ID: 19788429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes.
    Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
    Diabetes Res Clin Pract; 2008 Oct; 82(1):139-47. PubMed ID: 18703252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.
    Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
    Eur Heart J; 2008 Jan; 29(2):166-76. PubMed ID: 18156614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006-2013.
    Norhammar A; Bodegård J; Nyström T; Thuresson M; Eriksson JW; Nathanson D
    Diabetologia; 2016 Aug; 59(8):1692-701. PubMed ID: 27189067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 2 diabetes mellitus increases long-term mortality risk after isolated surgical aortic valve replacement.
    Ram E; Kogan A; Levin S; Fisman EZ; Tenenbaum A; Raanani E; Sternik L
    Cardiovasc Diabetol; 2019 Mar; 18(1):31. PubMed ID: 30876424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the use of anti-diabetic drugs on survival of diabetic dialysis patients: a 5-year retrospective cohort study in Taiwan.
    Hsiao PJ; Wu KL; Chiu SH; Chan JS; Lin YF; Wu CZ; Wu CC; Kao S; Fang TC; Lin SH; Chen JS
    Clin Exp Nephrol; 2017 Aug; 21(4):694-704. PubMed ID: 27599981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.
    Colhoun HM;
    Diabetologia; 2009 Sep; 52(9):1755-65. PubMed ID: 19603149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study.
    Wong CKH; Man KKC; Shi M; Chan EW; Ho CW; Tse ETY; Wong ICK; Lam CLK
    PLoS Med; 2019 Dec; 16(12):e1002999. PubMed ID: 31877127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation.
    Abizaid A; Kornowski R; Mintz GS; Hong MK; Abizaid AS; Mehran R; Pichard AD; Kent KM; Satler LF; Wu H; Popma JJ; Leon MB
    J Am Coll Cardiol; 1998 Sep; 32(3):584-9. PubMed ID: 9741497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus.
    Genuth S
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):104-9. PubMed ID: 8554200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral hypoglycemics: increased postoperative mortality in coronary risk patients.
    Jeger RV; Seeberger MD; Keller U; Pfisterer ME; Filipovic M
    Cardiology; 2007; 107(4):296-301. PubMed ID: 17264509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.